Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Sell
45
CHMX Quote, Financials, Valuation and Earnings
Last price:
$4.07
Seasonality move
:
-3.19%
Day range:
$4.05 - $4.06
52-week range:
$1.90 - $9.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
200
Avg. volume:
884
1-year change:
-54.89%
Market cap:
$115.9M
Revenue:
--
EPS (TTM):
-$0.06
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Next-ChemX has -- downside to fair value with a price target of -- per share.
CHMX vs. S&P 500
-
Over the past 5 trading days, Next-ChemX has overperformed the S&P 500 by 0.37% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Next-ChemX does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Next-ChemX has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Next-ChemX reported revenues of --.
Earnings Growth
-
Next-ChemX has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Next-ChemX reported earnings per share of -$0.01.
Enterprise value:
117.9M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-1.28x
EV / Free cash flow:
-97.29x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$2M | -$1.9M | -$1.7M | -$403.4K | -$319.4K | |
| EBITDA | -$2M | -$2.2M | -$1.6M | -$902.1K | -$303.7K | |
| Diluted EPS | -$0.07 | -$0.08 | -$0.06 | -$0.03 | -$0.01 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $379.2K | $62.7K | $3K | $235.3K | $694.7K | |
| Total Assets | $436.2K | $3.2M | $3.2M | $3.4M | $3.9M | |
| Current Liabilities | $150.5K | $652.1K | $2.2M | $3.4M | $4.5M | |
| Total Liabilities | $156.1K | $652.1K | $2.2M | $3.4M | $5.7M | |
| Total Equity | $280.1K | $2.6M | $988.6K | -$46.7K | -$1.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$690K | -$812.7K | -$1.2M | -$196.8K | -$171.3K | |
| Cash From Investing | -$1.6K | -- | -- | -- | -- | |
| Cash From Financing | $690.5K | $873.5K | $1.2M | $200K | $206K | |
| Free Cash Flow | -$691.6K | -$812.7K | -$1.2M | -$196.8K | -$171.3K | |
CHMX
Sector
Market Cap
$115.9M
$740.4M
Price % of 52-Week High
45.11%
78.59%
Dividend Yield
0%
0%
Shareholder Yield
--
2.32%
1-Year Price Total Return
-54.89%
-0.89%
Beta (5-Year)
-0.014
0.914
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$4.00
200-day SMA
Buy
Level
$2.80
Bollinger Bands (100)
Buy
Level
2.42 - 3.74
Chaikin Money Flow
Buy
Level
156.6K
20-day SMA
Buy
Level
$3.92
Relative Strength Index (RSI14)
Buy
Level
87.95
ADX Line
Sell
Level
41.2
Williams %R
Neutral
Level
-26.7123
50-day SMA
Buy
Level
$3.67
MACD (12, 26)
Buy
Level
0.11
25-day Aroon Oscillator
Buy
Level
8
On Balance Volume
Neutral
Level
132.3K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Next-ChemX Corp owns a Novel Membrane-Based Ion Extraction Technology called NCX technology, that economically extracts ions from solutions that are in very low concentrations. The company's extraction technology allows a continuous transfer without high pressure, temperature, or electrolysis as it mimics biological processes found in nature. Currently, The company is developing commercial pilot plant systems in its laboratory for a wide range of extraction applications that it intends to market Internationally.
Stock Forecast FAQ
In the current month, CHMX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CHMX average analyst price target in the past 3 months is --.
-
Where Will Next-ChemX Stock Be In 1 Year?
According to analysts, the consensus estimate is that Next-ChemX share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Next-ChemX?
Analysts are divided on their view about Next-ChemX share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Next-ChemX is a Sell and believe this share price will rise from its current level to --.
-
What Is Next-ChemX's Price Target?
The price target for Next-ChemX over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CHMX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Next-ChemX is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CHMX?
You can purchase shares of Next-ChemX via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Next-ChemX shares.
-
What Is The Next-ChemX Share Price Today?
Next-ChemX was last trading at $4.07 per share. This represents the most recent stock quote for Next-ChemX. Yesterday, Next-ChemX closed at $4.06 per share.
-
How To Buy Next-ChemX Stock Online?
In order to purchase Next-ChemX stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will T-Mobile Stock Recover?
Last year was a stellar year for telecom giant T-Mobile…
Why Is Stanley Druckenmiller Buying Citigroup?
As recently as 2020, few analysts could have predicted that…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
40
NUKK alert for Jan 17
Nukkleus [NUKK] is up 45.98% over the past day.
Sell
45
NUTX alert for Jan 17
Nutex Health [NUTX] is up 2.83% over the past day.
Buy
53
QMCO alert for Jan 17
Quantum [QMCO] is down 15.61% over the past day.
